Headquartered in Winston-Salem, ProKidney leases an undetermined amount of space at the general-industrial-zoned building at ...

Biotech company ProKidney will no longer be coming to Greensboro, according to the City of Greensboro Chamber of Commerce.

It is unclear what will happen to ProKidney's plans for a $458-million, 330-job commercial manufacturing facility in ...

The 73 Business Center on Greenbourne Drive in Greensboro is pictured. ProKidney Corp., a Winston-Salem company focused on ...

"We remain committed to bringing jobs to North Carolina.” WFMY News 2 followed back up with the company asking for clarify ...

“Notably, the FDA also confirmed that ProKidney could consider using eGFR slope as a surrogate endpoint on an accelerated approval pathway for rilparencel. We look forward to continuing our dialogue ...

ProKidney's REACT® therapy shows kidney function stabilization. Find out why PROK stock is risky due to cash issues and ...

Judah Frommer, an analyst from Morgan Stanley, maintained the Hold rating on ProKidney (PROK – Research Report). The associated price target remains the same with $3.00. Judah Frommer has given his ...

“Notably, the FDA also confirmed that ProKidney could consider using eGFR slope as a surrogate endpoint on an accelerated approval pathway for rilparencel. We look forward to continuing our ...

“Notably, the FDA also confirmed that ProKidney could consider using eGFR slope as a surrogate endpoint on an accelerated approval pathway for rilparencel. We look forward to continuing our ...